Related Experiment Video
Updated: Aug 20, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Escherichia coli: a growing problem in early onset neonatal sepsis
Bronwyn Jones1, Kirstie Peake, Arthur J Morris
1National Women's Hospital, Auckland, New Zealand.
Insights
Early-onset Escherichia coli sepsis in newborns is linked to high mortality rates and significant neurodevelopmental impairment in survivors. Amoxicillin resistance is prevalent, but gentamicin resistance remains low in local E. coli isolates.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Microbiology
Background:
- Early-onset neonatal sepsis poses a significant threat to infant health.
- Escherichia coli is a common pathogen causing neonatal sepsis.
- Understanding risk factors and outcomes is crucial for improving neonatal care.
Purpose of the Study:
- To examine the characteristics, risk factors, and outcomes of early neonatal sepsis caused by Escherichia coli.
- To assess antenatal antibiotic use.
- To determine the antimicrobial susceptibility of E. coli isolates.
Main Methods:
- Retrospective chart review of infants with E. coli-positive blood or cerebrospinal fluid cultures.
- Data collected from January 1998 to October 2002.
- Analysis of demographic data, pregnancy complications, birth outcomes, and antimicrobial resistance patterns.
Main Results:
- Twenty cases of E. coli sepsis identified (19 liveborn, 1 stillborn).
- High incidence of preterm birth (90%) and pregnancy complications (e.g., preterm rupture of membranes, 50%).
- Mortality rate was 40% (8/20); 33% of survivors had neurodevelopmental impairment.
Conclusions:
- Early-onset E. coli sepsis is associated with severe outcomes, including high mortality and neurodevelopmental deficits.
- High amoxicillin resistance rates were observed in E. coli isolates.
- Gentamicin resistance was low, suggesting its potential utility in treatment regimens.
Aims:
To review the demographic characteristics, antecedents and outcome for early neonatal Escherichia coli sepsis. Secondary aims were to identify antenatal antibiotic use and to review the antimicrobial susceptibility.
Methods:
A retrospective chart review was performed for all infants with a positive culture for E. coli from either blood or CSF samples obtained between January 1998 and October 2002.
Results:
Nineteen liveborn infants with early onset sepsis and one stillborn baby with a positive maternal blood culture for E. coli were identified. Pregnancy complications included multiple pregnancy in five (25%), preterm rupture of membranes 10 (50%) and maternal urinary tract infection in five (25%). Eighteen of the cases were born preterm and two at term. The mortality was 8/20 (40%), and for nine cases with developmental outcome data available, 67% were within normal limits and 33% were abnormal. Of the 20 E. coli isolates 11 (55%) were resistant to amoxycillin and 1 (5%) was resistant to gentamicin.
Conclusions:
Infants with early onset E. coli sepsis had a poor outcome with high mortality and a third of the survivors manifesting neurodevelopmental impairment. Although amoxycillin resistance is common, there is a low prevalence of gentamicin resistance in local isolates.
Related Concept Videos
Bacterial Gastroenteritis
Development of the Oral Microbiota
Microbiota of the Urogenital Tract
Development of Human Microbiota
Urinary Tract Infection II: Pathophysiology
Staphylococcal Skin Infections
